Interesting line: "In July of this year, 23andMe closed a deal with pharmaceutical giant GlaxoSmithKline (GSK) to grant it exclusive rights to mine its customers’ de-identified DNA data for future drug targets. Before that, 23andMe already had multiple deals with pharmaceutical companies, such as Genentech and Pfizer, to support their medical research.

https://observer.com/2018/09/23andme-data-law-enforcement-help/